Navigation Links
Transgenomic Reports Third Quarter Financial Results
Date:11/15/2010

of last year. The pipeline of proposals submitted to pharmaceutical companies stood at $7.0 million as of September 30, compared with $6.0 million as of June 30, and $2 million as of March 31, 2010. Existing signed contracts have approximately $1.7 million of potential net sales remaining.  We believe that we are very well positioned to benefit from the growing use of biomarker discovery in the treatment of patients.

"Along with our licensing partner, IntegraGen, we continued to market our new ARISk™ test, which determines if there is an increased risk of autism in a newborn with an autistic older biological sibling.  This test gives us the opportunity to derive revenues through both the kit sales and from performing this assay in our CLIA-certified laboratory.

"We continue to rightsize our operational footprint by consolidating our research and development activities in Omaha, Nebraska, reducing headcount and eliminating open positions.  Although there will be some one-time costs for these measures, these actions are expected to allow us to be cash flow positive in 2011," Mr. Tuttle concluded.

Conference CallManagement will discuss third quarter 2010 financial results and answer questions during a conference call to be held Monday, November 22, 2010 beginning at 5:00 p.m. Eastern time. To access the call via telephone, please dial 888-563-6275 (domestic) or 706-643-3137 (international) and enter conference ID number 24244484.  The call also will be broadcast live over the Internet. To listen to the webcast, please log onto the Company's Investor Relations web page at http://www.transgenomic.com/events.asp?id=6 and follow the instructions. An archived webcast of the call will be available for 30 days. Investors can listen to a replay via telephone until 11:59 p.m. Eastern time on Wednesday, December 22, 2010 by dialing 800-642-1687 (domestic) or 706-645-9291
'/>"/>

SOURCE Transgenomic, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Transgenomic Awarded $1,070,453 From U.S. Government Under the Patient Protection and Affordable Care Act
2. Transgenomic to Hold Third Quarter Financial Results Conference Call on November 15, 2010
3. Transgenomic Develops New Assays to Detect EGFR Mutations Using COLD-PCR
4. Dr. Eric Johnson Joins Transgenomic as Medical Director for Laboratory Services
5. Transgenomic Names Dr. Katherine Richardson Technical Director for Laboratory Services
6. Transgenomic Licenses IP From IntegraGen to Develop Genetic Test for Autism
7. Transgenomic Presents at 12th Annual BIO CEO & Investor Conference
8. Transgenomic Announces the Commercial Launch of SURVEYOR(R) Scan K-RAS Mutation Detection Kit
9. Transgenomic, Inc. Reports Third Quarter 2009 Results
10. Transgenomic and Power3 Medical Report Identification of Abnormal Serum Proteins in Parkinsons Disease
11. Transgenomic, Inc. Reports Second Quarter 2009 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... MD (PRWEB) May 23, 2013 Can ... off from work motivate members of the public to ... researchers including Johns Hopkins Carey Business School ... emphatic yes. Pointing to a large body of recent ... in the May 24, 2013, issue of Science that ...
(Date:5/23/2013)... PuraMed BioScience ® , Inc., (OTCBB: ... (OTC) medicinal and healthcare products, announced that Ludlow ... based on low market capitalization valuation. ... Product to Treat Migraine Headaches , Clinical ... , Currently Available Nationwide at Walgreen,s and ...
(Date:5/23/2013)... 23, 2013 PI’s new LPS-24 ... provide 15 mm travel range with closed-loop sensor ... dimensions make these new positioners the ideal choice ... vacuum rated version is also available. , ... datasheets can be found at: , http://www.physikinstrumente.com/en/products/prdetail.php?sortnr=1000745&prw-lps24 ...
(Date:5/23/2013)... 23, 2013 Virobay, Inc. today announced that ... reached an important milestone, as Virobay has now initiated ... selective cathepsin S inhibitor.   The first ... placebo-controlled study designed to evaluate the safety, tolerability, pharmacokinetics ... adults. "The initiation of this Phase 1 ...
Breaking Biology Technology:Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 2Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 3PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 2PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 3Precision Positioning System Uses Miniaturezed Piezo Linear Motor: LPS-24 Linear Stage by PI 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 3
... six Wisconsin biotech companies will present at an upcoming ... another signal of the rising influence of regional gatherings ... travel to Minneapolis for the Sept. 21-23 BIO ... Organization . Companies will present business plans and technology ...
... publication DM Review based in Wisconsin, announced ... competition. , ,The award, a symbol of excellence within ... given out since 1996. Entries are accepted in categories ... by feedback from DM Review readers. , ,Winners will ...
... Wis. - The Center for Technology Transfer ... LLC, a company that has developed a series of ... reduce usage of natural gas in their furnaces. , ,The ... will help Spinworks expand its business and product offerings, the ...
Cached Biology Technology:Six Wisconsin firms to present at BIO Mid-America VentureForum 2Six Wisconsin firms to present at BIO Mid-America VentureForum 3DM Review announces award finalists 2Tech center supports energy-saving device for heat-treating plants 2
(Date:5/22/2013)... (May 22, 2013)The omega 3 fatty acids in fish ... diseaseso much so that the American Heart Association currently ... week, particularly fatty varieties rich in omega 3s. However, ... mystery. In a new study, scientists led by Jason ... this phenomenon by providing evidence that fish oil might ...
(Date:5/22/2013)... the whole organism, as they may lead to life-threatening ... now report how byproducts of respiration cause mispairing of ... our cells controls the form and function of every ... are encoded in the linear sequence of the four ... (C), guanine (G) and thymine (T). Random changes in ...
(Date:5/22/2013)... Irvine, Calif., May 22, 2013 Early screening for ... personal pregnancy testing is for women, thanks to UC ... the American Chemical Society . , After more than ... a way to clearly identify clinically usable markers for ... be detected far sooner, with greater accuracy and at ...
Breaking Biology News(10 mins):Fish oil may help the heart beat mental stress 2DNA damage: The dark side of respiration 2UCI chemists devise inexpensive, accurate way to detect prostate cancer 2UCI chemists devise inexpensive, accurate way to detect prostate cancer 3
... Primate Research Center, Emory University, have successfully generated ... toward unlocking the genetic secrets of pair bonding. ... enable scientists to perform a host of genetic ... of social bonding and other complex social behaviors. ...
... German . , Brown adipose tissue is different from ... stations which among other things can ,burn, fat. In doing this, ... which then provides energy for cellular processes. However, the mitochondria of ... ahead all the time. The energy released when the fat is ...
... the scientists, one from the United States, the other from Canada, ... pack, on remote Ellesmere Island, only 600 miles from the North ... Pole wolves" do in the long, dark days of winter in ... 9-year-old Brutus back in 2003," said David Mech, a renowned U.S. ...
Cached Biology News:Yerkes researchers create first transgenic prairie voles 2Brown fat cells make 'spare tires' shrink 2North Pole wolf emails locations to researchers 2North Pole wolf emails locations to researchers 3
AANAT [Arylalkylamine N-acetyltransferase; EC 2.3.1.87]...
TUP1 Market Segment: Molecular Biology...
NANS Immunogen: NANS (NP_061819, 260 a.a. ~ 360 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Mouse monoclonal [050-04] to C2 ( Abpromise for all tested applications). entrezGeneID: 717 SwissProtID: P06681...
Biology Products: